Israel is quickly becoming a hotbed for AI in healthcare thanks to new investments to combine digital health records into a giant system that creates true interoperability to maximize use of AI programs and data analytics, The Wall Street Journal reported.

Some drugs to treat and prevent heartburn may contain traces of human carcinogens, according to a Sept. 13 warning from the FDA.

The chances of surviving oral cancer can now be predicted from AI algorithms by measuring immune cells in tumors.

Purdue Pharma, a drug manufacturer and maker of the popular opioid OxyContin, filed for bankruptcy in the fallout of thousands of lawsuits targeting the company for its role in the national opioid abuse and overdose epidemic.

Emerging technologies like AI and robotics have vast potential to improve healthcare. Few question this. What remains unclear is how meaningful the advances will be to healthcare providers and, more to the point, the patients they serve.

The Mayo Clinic has selected Google Cloud to anchor its digital development over the next 10 years.

Civica Rx, a not-for-profit drug company with $100 million in funding that aims to combat drug shortages, has inked its next deal with Exela Pharma Sciences to supply its membership of hospitals with sodium bicarbonate injections.

Fresh off the heels of its announcement to enter primary care with its own clinic, retail giant Walmart is preparing a big push into the healthcare space.

Two major companies are joining forces in a 10-year strategic partnership to accelerate healthcare innovation through digital technologies.

The rate of uninsured Americans in 2018 rose for the first time since the Affordable Care Act went into place, according to new data from the Census Bureau.